Patients News | pharmaphorum

News

AstraZeneca partners Capitainer on biomarker project

Swedish medtech start-up Capitainer has started working with AstraZeneca on a project to use a device for sampling cell-free blood in clinical trial programmes.

News

US court rejects J&J's talc bankruptcy deal

Shares in Johnson & Johnson have come under pressure amid reports that an appeals court in the US has rejected the bankruptcy petition filed by a new company it formed

News

Could your loyalty card help spot cancer? Study says yes

A study by UK researchers has found that buying patterns for over-the-counter (OTC) medicines for pain and indigestion, recorded using a store loyalty card, could be used to pick up early s

News

J&J copay lawsuit against drug benefit firm gets green light

Johnson & Johnson has been cleared to continue a lawsuit filed last year against drug benefit programme SaveOnSP, which claims it defrauded a payment assistance programme for patients o

News

Hilversum, The Netherlands - April 03, 2014. Image of a touch screen Android phone with social media apps.

ABPI code updated with first social media guidance

Guidance on the way pharma companies communicate about prescription medicines has been updated in the UK to cover use of social media channels for the first time.

News

NICE recommends first CAR-T cell therapy on NHS in England

Gilead Sciences and Kite, a Gilead company, have announced that the National Institute for Health and Care Excellence (NICE) has recommended Yescarta (axicabtagene ciloleucel; axi-cel) for

AstraZeneca partners Capitainer on biomarker project

US court rejects J&J's talc bankruptcy deal

Could your loyalty card help spot cancer? Study says yes

J&J copay lawsuit against drug benefit firm gets green light

ABPI code updated with first social media guidance

NICE recommends first CAR-T cell therapy on NHS in England

Bankruptcy threat looms as Quince runs out of options

How to meet your physicians where they are online

News

Editor's Picks